INNOVID CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.32 USD | +2.65% |
|
+12.62% | +54.67% |
| 08/05 | Needham Adjusts Price Target on Innovid to $3 From $2.25, Maintains Buy Rating | MT |
| 07/05 | Transcript : Innovid Corp., Q1 2024 Earnings Call, May 07, 2024 |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 791 | 228.5 | 210.8 | 279.8 | - | - |
| Enterprise Value (EV) 1 | 791 | 201 | 210.8 | 241.7 | 213 | 180.2 |
| P/E ratio | -2.01 x | -12.2 x | -6.52 x | -48.5 x | 41.6 x | 17.6 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 8.76 x | 1.8 x | 1.51 x | 1.73 x | 1.54 x | 1.4 x |
| EV / Revenue | 8.76 x | 1.58 x | 1.51 x | 1.49 x | 1.17 x | 0.9 x |
| EV / EBITDA | 145 x | 164 x | 10.9 x | 8.77 x | 6.18 x | 3.89 x |
| EV / FCF | -12,80,08,053 x | - | - | - | - | - |
| FCF Yield | -0% | - | - | - | - | - |
| Price to Book | - | 1.11 x | - | 1.34 x | 1.2 x | 1.05 x |
| Nbr of stocks (in thousands) | 1,18,942 | 1,33,651 | 1,40,564 | 1,44,245 | - | - |
| Reference price 2 | 6.650 | 1.710 | 1.500 | 1.940 | 1.940 | 1.940 |
| Announcement Date | 24/02/22 | 24/02/23 | 27/02/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 90.29 | 127.1 | 139.9 | 161.7 | 181.6 | 199.7 |
| EBITDA 1 | - | 5.446 | 1.225 | 19.42 | 27.56 | 34.46 | 46.27 |
| EBIT 1 | - | -5.849 | -29.74 | -32.96 | 16.5 | 8.816 | 24.59 |
| Operating Margin | - | -6.48% | -23.4% | -23.56% | 10.2% | 4.85% | 12.31% |
| Earnings before Tax (EBT) 1 | - | -10.24 | -16.39 | -29.54 | -0.8 | 7.616 | 22.39 |
| Net income 1 | -0.812 | -88.54 | -18.41 | -31.91 | -2.35 | 5.915 | 17.69 |
| Net margin | - | -98.06% | -14.48% | -22.81% | -1.45% | 3.26% | 8.86% |
| EPS 2 | -0.6800 | -3.310 | -0.1400 | -0.2300 | -0.0400 | 0.0467 | 0.1100 |
| Free Cash Flow | - | -6.179 | - | - | - | - | - |
| FCF margin | - | -6.84% | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 10/11/21 | 24/02/22 | 24/02/23 | 27/02/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 25.97 | 25.86 | 33.09 | 34.47 | 33.7 | 30.48 | 34.55 | 36.23 | 38.62 | 36.74 | 39 | 40.8 | 44 | - |
| EBITDA 1 | 1.795 | -3.009 | -1.66 | 2.866 | 3.029 | 0.145 | 4.542 | 6.456 | 8.275 | 4.396 | 5.8 | 7.2 | 9.7 | - |
| EBIT 1 | -6.702 | -9.797 | -9.174 | -6.031 | -4.739 | -8.214 | -17.87 | -4.322 | -2.549 | -3.1 | -1 | - | 4.45 | - |
| Operating Margin | -25.81% | -37.88% | -27.73% | -17.5% | -14.06% | -26.94% | -51.73% | -11.93% | -6.6% | -8.44% | -2.56% | - | 10.11% | - |
| Earnings before Tax (EBT) 1 | -7.21 | -7.486 | 4.132 | -10.99 | -2.046 | -5.739 | -17.62 | -4.032 | -2.142 | -3.058 | -1 | - | 3.7 | - |
| Net income 1 | -31.69 | -7.449 | 4.3 | -11.83 | -3.429 | -8.563 | -18.96 | -2.731 | -1.658 | -6.234 | -1 | - | 3 | - |
| Net margin | -122.03% | -28.8% | 13% | -34.33% | -10.18% | -28.09% | -54.88% | -7.54% | -4.29% | -16.97% | -2.56% | - | 6.82% | - |
| EPS 2 | -0.5900 | -0.0600 | 0.0300 | -0.0900 | -0.0300 | -0.0600 | -0.1400 | -0.0200 | -0.0100 | -0.0400 | -0.005000 | - | 0.0100 | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 24/02/22 | 06/05/22 | 10/08/22 | 11/11/22 | 24/02/23 | 09/05/23 | 08/08/23 | 08/11/23 | 27/02/24 | 07/05/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | - | 27.5 | - | 38.1 | 66.8 | 99.7 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | -6.18 | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | -10% | - | -3.12% | 3.38% | 6.92% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share 2 | - | - | 1.540 | - | 1.450 | 1.610 | 1.850 |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | - | 0.55 | - | - | - | - | - |
| Capex / Sales | - | 0.61% | - | - | - | - | - |
| Announcement Date | 10/11/21 | 24/02/22 | 24/02/23 | 27/02/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.94
USD
Average target price
2.733
USD
Spread / Average Target
+40.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +54.67% | 280M | |
| +9.65% | 3,051B | |
| +6.79% | 83.97B | |
| +4.74% | 76.9B | |
| -13.91% | 54B | |
| +23.12% | 48.01B | |
| -24.39% | 46.47B | |
| +23.22% | 42.04B | |
| +62.94% | 38.34B | |
| -33.46% | 24.97B |
- Stock Market
- Equities
- CTV Stock
- Financials Innovid Corp.